On Friday, Shares of National Bank of Greece S.A. (NYSE:NBG), lost -2.29% to $1.28, regardless of financial stocks, that were moderately higher Friday with the NYSE Financial Sector Index climbing 0.3% and the S&P Financial 100 Index adding 0.5%.
National Bank of Greece S.A., together with its auxiliaries, provides diversified financial services. The company is involved in retail and commercial banking, asset administration, investment banking, brokerage, and insurance activities.
Shares of Eli Lilly and Company (NYSE:LLY), inclined 1.24% to $85.85, during its last trading session, after the pharmaceutical company had its price target raised to $92 from $77 by analysts at Leerink.
The firm issued a higher price target after after evaluating two drugs, evacetrapib for cholesterol and solanezumab for Alzheimer’s.
Leerink said its new target assumes a 50% chance of success for evacetrapib and a 20% to 30% probability of success for solanezumab.
With a clear success of either one of the two drugs, analysts expect Lilly shares to trade as high as $98 per share.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
